bufuralol has been researched along with tamoxifen in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Dalvie, D; Loi, CM; Smith, DA | 1 |
Doehmer, J; Eichelbaum, MF; Krebsfaenger, N; Mürdter, TE; Zanger, UM | 1 |
Doehmer, J | 1 |
Don, CG; Smieško, M | 1 |
5 other study(ies) available for bufuralol and tamoxifen
Article | Year |
---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
V79 Chinese hamster cells genetically engineered for polymorphic cytochrome P450 2D6 and their predictive value for humans.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cell Line; Cricetinae; Cricetulus; Cytochrome P-450 CYP2D6; Drug Interactions; Ethanolamines; Gene Expression Regulation, Enzymologic; Genetic Engineering; Genetic Variation; Genetic Vectors; Hydroxylation; Polymorphism, Genetic; Quinidine; RNA, Messenger; Selective Estrogen Receptor Modulators; Tamoxifen; Transfection | 2003 |
The use and value of in vitro technologies in metabolism studies.
Topics: Adrenergic beta-Antagonists; Animal Testing Alternatives; Animals; Antineoplastic Agents, Hormonal; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Cytochrome P-450 CYP2D6; Drug Evaluation, Preclinical; Ethanolamines; Gene Expression Regulation, Enzymologic; Humans; In Vitro Techniques; Recombinant Proteins; Tamoxifen | 2009 |
Microsecond MD simulations of human CYP2D6 wild-type and five allelic variants reveal mechanistic insights on the function.
Topics: Alleles; Benzimidazoles; Catalytic Domain; Cytochrome P-450 CYP2D6; Dextromethorphan; Enzyme Inhibitors; Ethanolamines; Heme; Humans; Hydrogen Bonding; Inactivation, Metabolic; Molecular Dynamics Simulation; Substrate Specificity; Tamoxifen | 2018 |